Joint Action on Health Promotion and Disease Prevention including Smoke and Aerosol Free Environments
- Project No.: 101233428
- Project acronym: JA-SAFE
- Principal investigator (LSMU): Dr. Renata Kudukytė-Gasperė
- Project coordinator: Ethniko kai Kapodistriako Panepistimio Athinon (UOA), Greece
- Project duration: from 2025-10-15 to 2029-10-14
- Total project value: 15 998 385,82 Euro
- Part of the project value allocated to the LSMU: 420 526,05 Euro
- Funding programme: EU4HEALTH
- Project website: www.jasafe.org
The aim of this joint action is to reduce the burden of NCDs including cancer, and their risk factors, both at the individual and population level. Smoking and other forms of tobacco consumption are considered the single most important cause of preventable morbidity and premature mortality worldwide, with tobacco being the single major cause of premature deaths in the European Union (EU). The Joint Action on Health Promotion and Disease Prevention including Smoke and Aerosol Free Environments” (JA-SAFE) aims to significantly reduce tobacco use and exposure to secondhand smoke across Europe, contributing to the EU’s goal of achieving a tobacco-free generation. The project encompasses nine work packages under five thematic areas, smoke free environments, alcohol prevention, cessation, steps towards a tobacco free generation and supporting health promotion and disease prevention in Europe.
The main results of JARED project:
- Reduced tobacco use and exposure to second-hand smoke
- Stronger smoke- and aerosol-free environments across Europe
- Improved cessation support systems
- Enhanced cooperation and coordinated action among EU Member States in NCD prevention
This project is funded by the European Union under the EU4Health Programme (Grant Agreement No 101233428). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them.
PROJECT PARTNERS
- Sciensano (SCIENSANO), Belgium
- Univerzitet u Banjoj Luci (UNIBL), Bosnia and Herzegovina
- Federal Ministry of Health (FMZ), Bosnia and Herzegovina
- Farmaceutsko Drustvo Republike Srpske (PSRS), Bosnia and Herzegovina
- Cyprus National Addictions Authority (NAAC), Cyprus
- Statni Zdravotni Ustav (SZU), Czechia
- Hrvatski Zavod za Javno Zdravstvo (CIPH), Croatia
- Aarhus Kommune (AAKS), Denmark
- Region Syddanmark (UHSD), Denmark
- Region Sjaelland (RZ), Denmark
- Tervise Arengu Instituut (TAI), Estonia
- Terveyden ja Hyvinvoinnin Laitos (THL), Finland
- Ministre de la Sante et de l’Acces aux Soins (MoH FR), France
- TobaccoFree Research Institute Ireland (TFRI), Ireland
- Ethnikos Organismos Dimosias Ygeias (NPHO), Greece
- Orszagos Koranyi Pulmonologiai Intezet (NKIP), Hungary
- Istituto Superiore di Sanita (ISS), Italy
- Rigas Stradina Universitate (RSU), Latvia
- Lietuvos Sveikatos Mokslu Universitetas (LSMU), Lithuania
- Lietuvos Respublikos Sveikatos Apsaugos Ministerija (SAM LT), Lithuania
- Nacionalinis Vezio Institutas (NVI), Lithuania
- Vilniaus Universitetas (VU), Lithuania
- Rijksinstituut voor Volksgezondheid en Milieu (RIVM), Netherlands
- Ministerio da Saude (DGS), Portugal
- Instituto para os Comportamentos Aditivos e as Dependencias (ICAD), Portugal
- Institutul de Pneumoftiziologie Marius Nasta (IPMN), Romania
- Universitatea de Medicina si Farmacie Carol Davila din Bucuresti (CDU), Romania
- Nacionalni Institut za Javno Zdravje (NIJZ), Slovenia
- Institut Catala d’Oncologia (ICO), Spain
- Fundacion Publica Galega Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Spain
- Fundacion Instituto de Investigacion Marques de Valdecilla (IDIVAL), Spain
- Agencia de Salut Publica de Barcelona (ASPB), Spain
- Region Skane (LUND), Sweden
- State Institution Public Health Center of the Ministry of Health of Ukraine (PHC), Ukraine